ATE197052T1 - Topiramate-immunoassay, sowie analoge und antikörper - Google Patents

Topiramate-immunoassay, sowie analoge und antikörper

Info

Publication number
ATE197052T1
ATE197052T1 AT96942815T AT96942815T ATE197052T1 AT E197052 T1 ATE197052 T1 AT E197052T1 AT 96942815 T AT96942815 T AT 96942815T AT 96942815 T AT96942815 T AT 96942815T AT E197052 T1 ATE197052 T1 AT E197052T1
Authority
AT
Austria
Prior art keywords
topiramate
immunoassay
antibodies
analogues
add
Prior art date
Application number
AT96942815T
Other languages
English (en)
Inventor
Kenneth J Stenglein
Daniel B Cawley
Bruce E Maryanoff
Kirk L Sorgi
Original Assignee
Opus Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24257371&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE197052(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Opus Diagnostics Inc filed Critical Opus Diagnostics Inc
Application granted granted Critical
Publication of ATE197052T1 publication Critical patent/ATE197052T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9473—Anticonvulsants, e.g. phenobarbitol, phenytoin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT96942815T 1995-12-01 1996-11-27 Topiramate-immunoassay, sowie analoge und antikörper ATE197052T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/565,143 US5952187A (en) 1995-12-01 1995-12-01 Topiramate immunoassay
PCT/US1996/018971 WO1997019950A1 (en) 1995-12-01 1996-11-27 Topiramate immunoassay, as well as analogs and antibodies

Publications (1)

Publication Number Publication Date
ATE197052T1 true ATE197052T1 (de) 2000-11-15

Family

ID=24257371

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96942815T ATE197052T1 (de) 1995-12-01 1996-11-27 Topiramate-immunoassay, sowie analoge und antikörper

Country Status (9)

Country Link
US (1) US5952187A (de)
EP (1) EP0876385B1 (de)
JP (1) JP4435305B2 (de)
AT (1) ATE197052T1 (de)
AU (1) AU721665B2 (de)
CA (1) CA2239224C (de)
DE (1) DE69610716T2 (de)
ES (1) ES2153134T3 (de)
WO (1) WO1997019950A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0019593D0 (en) * 2000-08-10 2000-09-27 Norgine Europe Bv Production of bile acid derivatives
UA78211C2 (en) * 2001-07-09 2007-03-15 Ortho Mcneil Pharm Inc Salts of fructopyranose derivatives as anticonvulsant
ATE373240T1 (de) * 2001-07-13 2007-09-15 Diachemix Llc Auf fluoreszenzpolarisation beruhender homogener assay für aflatoxine
US6559293B1 (en) 2002-02-15 2003-05-06 Transform Pharmaceuticals, Inc. Topiramate sodium trihydrate
WO2003074474A2 (en) 2002-03-01 2003-09-12 University Of South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US20100311701A1 (en) * 2002-02-15 2010-12-09 Transform Pharmaceuticals, Inc Pharmaceutical Co-Crystal Compositions
US20090088443A1 (en) * 2002-02-15 2009-04-02 Julius Remenar Novel crystalline forms of conazoles and methods of making and using the same
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US7060725B2 (en) * 2002-05-13 2006-06-13 Janssen Pharmaceutica N.V. Substituted sulfamate anticonvulsant derivatives
US20070059356A1 (en) * 2002-05-31 2007-03-15 Almarsson Oern Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
JP2006500377A (ja) * 2002-06-21 2006-01-05 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド 改善された溶解性を有する医薬組成物
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
EP1730525B1 (de) * 2004-03-10 2013-06-19 Seradyn, Inc. Immuntests für everolimus
US7638291B2 (en) * 2004-10-25 2009-12-29 Seradyn, Inc. Immunoassays for topiramate
US20060088886A1 (en) * 2004-10-25 2006-04-27 Anlong Ouyang Topiramate analogs
PL2061458T3 (pl) * 2006-09-15 2015-07-31 Univ Minnesota Kompozycje topiramatu i sposoby ich stosowania
US20090239942A1 (en) 2006-09-15 2009-09-24 Cloyd James C Topiramate Compositions and Methods of Making and Using the Same
ES2525342T3 (es) * 2009-06-10 2014-12-22 Randox Laboratories Ltd. Inmunoensayo para antidepresivos basados en N-(3-clorofenil)piperazina
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN110655542A (zh) * 2018-06-29 2020-01-07 鲁南制药集团股份有限公司 一种2,3:4,5-双-O-(1-甲基亚乙基)-β-D-吡喃果糖氯磺酸酯的晶型
CN114685526A (zh) * 2020-12-25 2022-07-01 长沙博源医疗科技有限公司 一种托吡酯衍生物、免疫原、抗托吡酯特异性抗体及其制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU555213B2 (en) * 1981-02-17 1986-09-18 Abbott Laboratories N-substituted-amido-fluoresein derivatives
US4668640A (en) * 1981-12-11 1987-05-26 Abbott Laboratories Fluorescence polarization immunoassay utilizing substituted carboxyfluoresceins
US4492762A (en) * 1981-12-11 1985-01-08 Abbott Laboratories Fluorescent polarization immunoassays
EP0218010A3 (de) * 1985-07-10 1988-01-07 Abbott Laboratories Verfahren zur Bestimmung von Liganden und substituierte Carboxyfluoreszein-Markers zur Durchführung desselben
US4751190A (en) * 1985-07-22 1988-06-14 Abbott Laboratories Fluorescence polarization immunoassay and reagents for use therein
US5051361A (en) * 1988-10-19 1991-09-24 Sigma Chemical Company AZT immunoassays, derivatives, conjugates and antibodies
US5258402A (en) * 1992-06-11 1993-11-02 Mcneil-Ppc, Inc. Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates
US5384327A (en) * 1992-12-22 1995-01-24 Mcneilab, Inc. Anticonvulsant sorbopyranose sulfamates

Also Published As

Publication number Publication date
AU721665B2 (en) 2000-07-13
JP2000502888A (ja) 2000-03-14
CA2239224C (en) 2006-11-14
EP0876385A1 (de) 1998-11-11
WO1997019950A1 (en) 1997-06-05
DE69610716D1 (de) 2000-11-23
CA2239224A1 (en) 1997-06-05
US5952187A (en) 1999-09-14
AU1141697A (en) 1997-06-19
JP4435305B2 (ja) 2010-03-17
ES2153134T3 (es) 2001-02-16
EP0876385B1 (de) 2000-10-18
DE69610716T2 (de) 2001-05-10

Similar Documents

Publication Publication Date Title
ATE197052T1 (de) Topiramate-immunoassay, sowie analoge und antikörper
DK261386A (da) Monoklonale antistoffer
ATE161289T1 (de) Repamycinbestimmung
MY104946A (en) Antigen antibody conjugate.
EP0375422A3 (de) Zusammensetzung und Methoden zur Bestimmung der Anwesenheit von Amphetaminen in einer Probe, die in Verdacht steht, Amphetamine und/oder Metamphetamine zu enthalten
ATE112059T1 (de) Verfahren zur bestimmung eines analyten.
CA2172663A1 (en) Improved reagents for a cannabinoid immunoassay
GB9318612D0 (en) An assay
FR2733250B1 (fr) Anticorps monoclonaux anti-gp130, et leurs utilisations
AR022890A1 (es) Citoquinas mamiferas; reactivos relacionados y metodos
CA2246896A1 (en) Immunoassay utilizing two incubations with labelled antigen
ATE85363T1 (de) Verfahren und reagenz zur bestimmung von alphaamylase.
DE3884731D1 (de) Monoklonaler Antikörper gegen Methamphetamin, seine Herstellung, Testverfahren und Testsatz für Methamphetamin.
DE69839876D1 (de) Prostat-spezifisches-antigenformen und verfahren zu ihrer bestimmung
ES2126597T3 (es) Sistema de sondas que permite efectuar la tipificacion hla dr, y procedimiento de tipificacion que utiliza dichas sondas.
ATE294237T1 (de) S?ugetier thymokingene
DE3684223D1 (de) Monoklonale antikoerper.
FI86255B (fi) Monoklonal antiurokinase-antikropp, den innehaollande matris och biokemiska testpackningar, i vilka den anvaendes.
FR2599513B1 (fr) Anticorps monoclonaux inhibant la liaison de ige soluble aux lymphocytes humains, hybridomes monoclonaux produisant de tels anticorps, leur utilisation
PH21459A (en) Process for assaying atl virus antibody and reagent therefor
DE69922680D1 (de) Detektion und quantifikation von vancomycin in den biologischen flüssigkeiten
MX9704717A (es) Antigeno, anticuerpos y ensayo de diagnostico para la enfermedad de alzheimer.
TW288020B (en) Monoclonal antibodies specific to methamphetamine, hybridoma producing the antibodies, kits containing the antibodies and uses thereof
HUP9701386A2 (hu) Immunológiai vizsgálati eljárás
JPS5386014A (en) Quantitative analysis of antigen and antibody

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties